vs
AGREE REALTY CORP（ADC）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
AGREE REALTY CORP的季度营收约是REPLIGEN CORP的1.0倍（$200.8M vs $197.9M），AGREE REALTY CORP净利率更高（31.0% vs 6.7%，领先24.3%），AGREE REALTY CORP同比增速更快（18.7% vs 13.6%），过去两年AGREE REALTY CORP的营收复合增速更高（14.7% vs 14.4%）
杜克房地产是总部位于美国印第安纳州印第安纳波利斯的工业地产投资信托基金（REIT），主营工业类物业投资。截至2021年12月31日，公司持有或共同控制548处以工业用途为主的物业，可出租总面积达1.627亿平方英尺，2022年10月被普洛斯收购。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
ADC vs RGEN — 直观对比
营收规模更大
ADC
是对方的1.0倍
$197.9M
营收增速更快
ADC
高出5.1%
13.6%
净利率更高
ADC
高出24.3%
6.7%
两年增速更快
ADC
近两年复合增速
14.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $200.8M | $197.9M |
| 净利润 | $62.2M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 49.1% | 9.0% |
| 净利率 | 31.0% | 6.7% |
| 营收同比 | 18.7% | 13.6% |
| 净利润同比 | 32.0% | 143.9% |
| 每股收益（稀释后） | $1.04 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ADCRGEN
| Q1 26 | $200.8M | — | ||
| Q4 25 | $190.5M | $197.9M | ||
| Q3 25 | $183.2M | $188.8M | ||
| Q2 25 | $175.5M | $182.4M | ||
| Q1 25 | $169.2M | $169.2M | ||
| Q4 24 | $160.7M | $174.1M | ||
| Q3 24 | $154.3M | $154.9M | ||
| Q2 24 | $152.6M | $154.1M |
净利润ADCRGEN
| Q1 26 | $62.2M | — | ||
| Q4 25 | $56.0M | $13.3M | ||
| Q3 25 | $52.1M | $14.9M | ||
| Q2 25 | $49.2M | $14.9M | ||
| Q1 25 | $47.0M | $5.8M | ||
| Q4 24 | $45.2M | $-30.3M | ||
| Q3 24 | $44.4M | $-654.0K | ||
| Q2 24 | $54.7M | $3.3M |
毛利率ADCRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% |
营业利润率ADCRGEN
| Q1 26 | 49.1% | — | ||
| Q4 25 | 48.5% | 9.0% | ||
| Q3 25 | 47.6% | 8.9% | ||
| Q2 25 | 46.7% | 7.6% | ||
| Q1 25 | 46.5% | 3.9% | ||
| Q4 24 | 46.9% | -17.7% | ||
| Q3 24 | 48.2% | -5.1% | ||
| Q2 24 | 53.7% | 1.0% |
净利率ADCRGEN
| Q1 26 | 31.0% | — | ||
| Q4 25 | 29.4% | 6.7% | ||
| Q3 25 | 28.4% | 7.9% | ||
| Q2 25 | 28.0% | 8.2% | ||
| Q1 25 | 27.8% | 3.4% | ||
| Q4 24 | 28.1% | -17.4% | ||
| Q3 24 | 28.8% | -0.4% | ||
| Q2 24 | 35.9% | 2.2% |
每股收益（稀释后）ADCRGEN
| Q1 26 | $1.04 | — | ||
| Q4 25 | $0.47 | $0.24 | ||
| Q3 25 | $0.45 | $0.26 | ||
| Q2 25 | $0.43 | $0.26 | ||
| Q1 25 | $0.42 | $0.10 | ||
| Q4 24 | $0.41 | $-0.55 | ||
| Q3 24 | $0.42 | $-0.01 | ||
| Q2 24 | $0.52 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $25.1M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $6.2B | $2.1B |
| 总资产 | $10.2B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资ADCRGEN
| Q1 26 | $25.1M | — | ||
| Q4 25 | $16.3M | $767.6M | ||
| Q3 25 | $13.7M | $748.7M | ||
| Q2 25 | $5.8M | $708.9M | ||
| Q1 25 | $7.9M | $697.2M | ||
| Q4 24 | $6.4M | $757.4M | ||
| Q3 24 | $13.2M | $784.0M | ||
| Q2 24 | $9.6M | $809.1M |
总债务ADCRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益ADCRGEN
| Q1 26 | $6.2B | — | ||
| Q4 25 | $6.3B | $2.1B | ||
| Q3 25 | $5.9B | $2.1B | ||
| Q2 25 | $5.7B | $2.1B | ||
| Q1 25 | $5.6B | $2.0B | ||
| Q4 24 | $5.5B | $2.0B | ||
| Q3 24 | $5.3B | $2.0B | ||
| Q2 24 | $5.2B | $2.0B |
总资产ADCRGEN
| Q1 26 | $10.2B | — | ||
| Q4 25 | $9.8B | $2.9B | ||
| Q3 25 | $9.5B | $2.9B | ||
| Q2 25 | $9.1B | $2.9B | ||
| Q1 25 | $8.8B | $2.9B | ||
| Q4 24 | $8.5B | $2.8B | ||
| Q3 24 | $8.2B | $2.8B | ||
| Q2 24 | $8.0B | $2.9B |
负债/权益比ADCRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流ADCRGEN
| Q1 26 | — | — | ||
| Q4 25 | $504.1M | $25.7M | ||
| Q3 25 | $146.5M | $48.1M | ||
| Q2 25 | $119.6M | $28.6M | ||
| Q1 25 | $126.7M | $15.0M | ||
| Q4 24 | $432.0M | $39.2M | ||
| Q3 24 | $128.6M | $49.3M | ||
| Q2 24 | $112.8M | $42.2M |
自由现金流ADCRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $17.6M | ||
| Q3 25 | — | $43.4M | ||
| Q2 25 | — | $21.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | $89.4M | $33.6M | ||
| Q3 24 | $-87.4M | $42.3M | ||
| Q2 24 | $-74.8M | $37.4M |
自由现金流率ADCRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 8.9% | ||
| Q3 25 | — | 23.0% | ||
| Q2 25 | — | 11.8% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | 55.6% | 19.3% | ||
| Q3 24 | -56.6% | 27.3% | ||
| Q2 24 | -49.0% | 24.3% |
资本支出强度ADCRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | 213.1% | 3.2% | ||
| Q3 24 | 140.0% | 4.5% | ||
| Q2 24 | 123.0% | 3.1% |
现金转化率ADCRGEN
| Q1 26 | — | — | ||
| Q4 25 | 9.00× | 1.93× | ||
| Q3 25 | 2.81× | 3.23× | ||
| Q2 25 | 2.43× | 1.92× | ||
| Q1 25 | 2.70× | 2.57× | ||
| Q4 24 | 9.55× | — | ||
| Q3 24 | 2.90× | — | ||
| Q2 24 | 2.06× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
